These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16904898)

  • 41. Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites.
    Chouteau F; Ramanitrahasimbola D; Rasoanaivo P; Chibale K
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3024-8. PubMed ID: 15908208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]-Leu-enkephalin analogues.
    Gu X; Ying J; Min B; Cain JP; Davis P; Willey P; Navratilova E; Yamamura HI; Porreca F; Hruby VJ
    Biopolymers; 2005; 80(2-3):151-63. PubMed ID: 15660379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase.
    Allan AL; Gladstone PL; Price ML; Hopkins SA; Juarez JC; Doñate F; Ternansky RJ; Shaw DE; Ganem B; Li Y; Wang W; Ealick S
    J Med Chem; 2006 Dec; 49(26):7807-15. PubMed ID: 17181163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, total synthesis, and biological evaluation of neodysiherbaine A derivative as potential probes.
    Sasaki M; Tsubone K; Shoji M; Oikawa M; Shimamoto K; Sakai R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5784-7. PubMed ID: 16949819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
    Cappelli A; Nannicini C; Gallelli A; Giuliani G; Valenti S; Mohr Gl; Anzini M; Mennuni L; Ferrari F; Caselli G; Giordani A; Peris W; Makovec F; Giorgi G; Vomero S
    J Med Chem; 2008 Apr; 51(7):2137-46. PubMed ID: 18318468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives.
    Suzuki S; Okano T; Horiuchi R; Hareyama N; Amikura K; Yamamoto N; Yoshizawa Y; Yagi M; Serizawa K; Hayashi R
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3368-72. PubMed ID: 26087939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of novel N1-substituted bicyclic pyrazole amino acids and evaluation of their interaction with glutamate receptors.
    Conti P; Grazioso G; di Ventimiglia SJ; Pinto A; Roda G; Madsen U; Bräuner-Osborne H; Nielsen B; Costagli C; Galli A
    Chem Biodivers; 2005 Jun; 2(6):748-57. PubMed ID: 17192018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Kim JT; Hamilton AD; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
    J Am Chem Soc; 2006 Dec; 128(48):15372-3. PubMed ID: 17131993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and properties of gem-(difluorocyclopropyl)amine derivatives of bicyclo[n.1.0]alkanes.
    Nowak I; Cannon JF; Robins MJ
    Org Lett; 2004 Dec; 6(25):4767-70. PubMed ID: 15575681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
    Malpass JR; White R
    J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
    Potin D; Launay M; Nicolai E; Fabreguette M; Malabre P; Caussade F; Besse D; Skala S; Stetsko DK; Todderud G; Beno BR; Cheney DL; Chang CJ; Sheriff S; Hollenbaugh DL; Barrish JC; Iwanowicz EJ; Suchard SJ; Dhar TG
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1161-4. PubMed ID: 15686933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
    Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
    J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total synthesis based on the originally claimed structure of mucosin.
    Gallantree-Smith HC; Antonsen SG; Görbitz CH; Hansen TV; Nolsøe JM; Stenstrøm YH
    Org Biomol Chem; 2016 Sep; 14(36):8433-7. PubMed ID: 27529324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of sugar-derived Ras inhibitors.
    Peri F; Airoldi C; Colombo S; Martegani E; van Neuren AS; Stein M; Marinzi C; Nicotra F
    Chembiochem; 2005 Oct; 6(10):1839-48. PubMed ID: 16196015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of natural phaeosphaeride A derivatives and an in vitro evaluation of their anti-cancer potential.
    Abzianidze VV; Prokofieva DS; Chisty LA; Bolshakova KP; Berestetskiy AO; Panikorovskii TL; Bogachenkov AS; Holder AA
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5566-9. PubMed ID: 26508550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.
    Chiba T; Ohwada J; Sakamoto H; Kobayashi T; Fukami TA; Irie M; Miura T; Ohara K; Koyano H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7486-9. PubMed ID: 23122816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and modeling studies of a potent conformationally rigid muscarinic agonist: 1-azabicyclo[2.2.1]heptanespirofuranone.
    Wu ES; Kover A; Semus SF
    J Med Chem; 1998 Oct; 41(22):4181-5. PubMed ID: 9784090
    [No Abstract]   [Full Text] [Related]  

  • 60. Rapid and efficient synthesis of dysiherbaine and analogues to explore structure-activity relationships.
    Sasaki M; Tsubone K; Aoki K; Akiyama N; Shoji M; Oikawa M; Sakai R; Shimamoto K
    J Org Chem; 2008 Jan; 73(1):264-73. PubMed ID: 18052390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.